Patents Examined by Doan T Phan
  • Patent number: 10085925
    Abstract: A microcapsule composition useful in delivering an active material contains a first microcapsule and a second microcapsule. The first microcapsule has a zeta potential of 10 mV or greater, the second microcapsule has a zeta potential of 5 mV or less, and the weight ratio of the first microcapsule and the second microcapsule is between 1:10 and 10:1. Also disclosed are consumer products containing such a microcapsule composition.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: October 2, 2018
    Assignee: INTERNATIONAL FLAVORS & FRAGRANCES INC.
    Inventors: Yabin Lei, Lewis Michael Popplewell, Li Xu, John Brahms, Xiang Fei
  • Patent number: 10085941
    Abstract: The present invention relates to a composition for parenteral administration, containing donepezil as an active ingredient, and a preparation method therefor. Donepezil, which has been conventionally used for oral or transdermal administration, is prepared as microparticles comprising a biodegradable and biocompatible polymer and a release controller so as to be provided as a pharmaceutical composition for sustained release parenteral administration, thereby enabling in vivo sustained release continuously for 2-12 weeks or more. Therefore, it is possible to reduce the frequency of administration to a patient and maintain an effective concentration in the blood for a long time.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: October 2, 2018
    Assignee: DONGKOOK PHARMACEUTICAL CO., LTD.
    Inventors: Deok Keun Lee, Sung Jin Ko, Shin Eom, Kyung Hoi Cha
  • Patent number: 10086105
    Abstract: The invention provides a solid foam wound dressing useful for hemorrhage control and wound repair, as well as methods for making such a wound dressing.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: October 2, 2018
    Assignee: Providence Health System—Oregon
    Inventors: Jian Xin Guo, Kenton W. Gregory
  • Patent number: 10085928
    Abstract: A diglycerin derivative-modified silicone, wherein the diglycerin derivative-modified silicone contains a long chain alkyl group as a lipophilic group in a molecule, does not have an oxyalkylene structure wherein an average value of the number of repetitions of the oxyalkylene unit is two or more, has only a glycerin derivative group with an average value of the number of repetitions of glycerin units of 1.1 to 2.9 as a hydrophilic group, and does not have other hydrophilic group in the molecule; a surfactant and dispersing agent, an emulsifier for a water-in-oil emulsion, an external use preparation, and a cosmetic composition containing the same.
    Type: Grant
    Filed: December 26, 2012
    Date of Patent: October 2, 2018
    Assignee: DOW CORNING TORAY CO., LTD.
    Inventors: Sayuri Sawayama, Seiki Tamura, Seiji Hori
  • Patent number: 9987300
    Abstract: The present invention concerns a composition comprising micro particles of polyinosinic-polycytidylic acid (Poly (I:C)) and a carrier polymer selected from starch, alginate, blanose or DPPC (dipalmitoylphosphatidylcholine) for use in preventing and/or treating viral infections of the upper respiratory tract or the common cold and a device, preferably a nasal delivery system, comprising said composition for use by a patient in need to prevent and/or treat infections or the common cold.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: June 5, 2018
    Assignee: Janssen Sciences Ireland UC
    Inventors: Lieven Elvire Colett Baert, Bruce Albert Malcolm, Roger Paulus Maria Sutmuller
  • Patent number: 9949959
    Abstract: The instant invention relates to a semi-solid topical composition containing Pirfenidone and an antimicrobial/antiseptic agent such as Modified Diallyl Disulfide Oxide (M-DDO) and its preparation process, offering advantages compared to other pharmaceutical forms of topical administration known in the state of the art, useful as antifibrotic, anti-inflammatory and antiseptic agent in the prevention, treatment and reversion of acne and post acne lesions. Said compositions is also useful for reducing skin redness, detaining the formation of new acne outbreaks, reversing already existing outbreaks and regenerating skin damage caused by acne.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: April 24, 2018
    Assignee: CELL THERAPY AND TECHNOLOGY S.A. DE C.V.
    Inventors: Juan Socorro Armendáriz Borunda, José Agustín Rogelio Magaña Castro, Pedro Peña Santoyo, Laura Vázquez Cervantes
  • Patent number: 9925130
    Abstract: A personal care composition for application to the skin or hair comprising a cosmetically acceptable carrier and zinc X halide precursors wherein the precursors are a zinc ion source, an X source, and a halide source, wherein the halide source can be part of the zinc ion source, the X source, or a halogen acid, wherein the precursors can complex into the zinc X halide when the composition is applied to the skin or hair, wherein X is an amino acid or trimethylglycine. Methods of making and using the compositions are also provided. When the precursors complex into a zinc X halide, the complex can be used to deliver zinc salts to block perspiration and provide antibacterial effects.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: March 27, 2018
    Assignee: Colgate-Palmolive Company
    Inventors: Long Pan, Jairajh Mattai, Shamim Ansari, Jianhong Qiu, James G. Masters, Ying Yang
  • Patent number: 9918476
    Abstract: A method for manufacturing a parasiticidal composition comprising at least 40% of alkali metal bicarbonate and at least 1% of silica, wherein: at least 35% of the alkali metal bicarbonate of the composition is milled in the presence of silica in order to form a mixture of particles, and if necessary, the remainder of the alkali metal bicarbonate is added to the mixture of particles to form the parasiticidal composition, and wherein said parasiticidal composition has a particle size distribution such that at least 50% by weight of the particles have a diameter of less than 100 ?m. A parasiticidal composition obtained by the present method and the use of the parasiticidal composition obtained by the present method in the form of a powder, a suspension or a gel.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: March 20, 2018
    Assignee: Solvay SA
    Inventor: Jean-Philippe Pascal
  • Patent number: 9914795
    Abstract: Described herein is a class of non-homopolymers polymerized from at least: (A) 10-22 mole percent of at least one N-vinyl lactam, (B) 30-35 mole percent of at least one monomer selected from the group consisting of acrylic acid, methacrylic acid, and combinations thereof, (C) 40-52 mole percent of at least one (meth)acrylate of a straight- or branched-chain alkyl alcohol, and (D) 5-20 mole percent of at least one (meth)acrylate of a saturated or unsaturated cyclic alcohol having 6 to 20 carbon atoms. In one embodiment, the non-homopolymers exhibit solubility in the lower molecular weight alcohols. The non-homopolymers may be used in personal care or performance chemicals compositions. In one embodiment, the polymers are used in various personal care formulations, such as used for skin, sun, hair, and preservatives.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: March 13, 2018
    Assignee: ISP INVESTMENTS LLC
    Inventors: Xuejun Liu, Osama M. Musa
  • Patent number: 9877926
    Abstract: A bioadhesive formulation, comprising gelatin, alginate and a coupling agent, capable of forming a bioadhesive matrix, which is characterized by rapid curing, optimal viscosity, high bonding strength, flexibility, biocompatibility and biodegradability, is disclosed. Further disclosed is such a bioadhesive formulation which further comprises a bioactive agent, and a drug-eluting bioadhesive matrix formed therefrom, the bioadhesive matrix being capable of delivering the bioactive agent to a bodily site. Methods utilizing the bioadhesive formulations and matrices in various biological and medical procedures are also disclosed.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: January 30, 2018
    Assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Meital Zilberman, Adaya Shefy-Peleg, Binyamin Cohen, Maytal Foox
  • Patent number: 9867774
    Abstract: This invention is a natural lotion that exploits the benefits of Dead Sea salt for helping with the dry skin of a human body, especially on the arms, legs, hands and face. The lotion adds to a base of organic aloe vera juice, organic coconut oil, shea butter, sunflower oil, olive oil, NF emulsified wax (vegetable based), rose hydrosol, and apple cider vinegar. It also includes green tea extract and several pure essential oils like geranium, bergamot, sweet orange and patchouli.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: January 16, 2018
    Inventor: Noha N. Hakim
  • Patent number: 9833470
    Abstract: A dialysis acid precursor assembly including: a dry dialysis acid precursor composition including sodium chloride, a dry acid and a magnesium chloride 4.5-hydrate (MgCl2.4.5H2O), a calcium salt and at least one of a potassium salt, calcium salt and an anhydrous glucose, and a moisture-resistant container having a water vapor transmission rate less than 0.2 g/m2/d at 38° C./90% RH, wherein the dry dialysis acid precursor composition is sealed in the container.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: December 5, 2017
    Assignee: Gambro Lundia AB
    Inventors: Olof Jansson, Jens Gustafsson, Torbjorn Linden